<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<title>Titratable Medications Reference Table - Adventist Health</title>
<style>
        /* Adventist Health Brand Styles */
        body {
            font-family: Arial, Helvetica, sans-serif;
            margin: 0;
            font-size: 13px;
            line-height: 1.5;
        }
        
        .header {
            background-color: #003764;
            color: white;
            padding: 20px;
            text-align: center;
            margin: -20px -20px 20px -20px;
            border-bottom: 4px solid #00A0DD;
        }
        
        h1 {
            color: white;
            margin: 0;
            font-size: 28px;
            font-weight: 600;
            letter-spacing: 0.5px;
        }
        
        .subtitle {
            color: #00A0DD;
            font-size: 14px;
            margin-top: 8px;
            font-weight: 400;
        }
        
        .table-container {
            overflow-x: auto;
            background: white;
            padding: 10px;
            border-radius: 4px;
            box-shadow: 0 2px 8px rgba(0, 55, 100, 0.1);
        }
        
        table {
            width: 100%;
            border-collapse: collapse;
            margin-bottom: 30px;
            table-layout: auto;
        }
        
        th {
            background-color: #003764;
            color: white;
            padding: 16px 12px;
            text-align: center;
            font-weight: 600;
            font-size: 14px;
            border: 1px solid #00A0DD;
            position: sticky;
            top: 0;
            z-index: 10;
            letter-spacing: 0.5px;
        }
        
        td {
            padding: 10px 8px;
            border: 1px solid #D6EEF0;
            vertical-align: top;
            font-size: 12px;
            line-height: 1.4;
            color: #55565A;
        }
        
        tr:nth-child(even) {
            background-color: #E1F0FB;
        }
        
        tr:hover {
            background-color: #D6EEF0;
        }
        
        .medication-name {
            color: #003764;
            font-size: 14px;
            min-width: 100px;
        }
        
        .high-alert {
            background-color: #FDDDD7;
            border-left: 4px solid #F8485E;
        }
        
        .non-formulary {
            background-color: #FFE5C2;
        }
        
        .warning {
            color: #F8485E;
            font-weight: 600;
        }
        
        .concentration {
            white-space: pre-wrap;
            min-width: 50px;
        }
        
        .goal-param {
            white-space: normal;
            line-height: 1.4;
            /* Ensure goal parameter content is left-aligned */
            text-align: left;
        }
        
        .goal-param br::before {
            content: "• ";
            color: #003764;
        }
        
        .dosing {
            white-space: pre-wrap;
            min-width: 80px;
        }
        
        .comments {
            max-width: 450px;
            font-size: 11px;
            line-height: 1.0;
            color: #55565A;
            text-align: left;
            /* Use pre-line to preserve line breaks while collapsing leading
               whitespace from the HTML source. This prevents indented/tabbed
               rendering created by source formatting without requiring
               additional <br> tags. */
            white-space: pre-line;
        }
        
        /* Medication Category Colors */
        .neuromuscular-blocker {
            background-color: #FDDDD7;
        }
        
        .sedative {
            background-color: #E0DEF0;
        }
        
        .vasopressor {
            background-color: #F0F7E8;
        }
        
        .antihypertensive {
            background-color: #E1F0FB;
        }
        
        .analgesic {
            background-color: #FFFCDF;
        }
        
        .inotrope {
            background-color: #D6EEF0;
        }
        
        .footer {
            text-align: center;
            margin-top: 30px;
            padding: 20px;
            color: #55565A;
            font-size: 10px;
            border-top: 2px solid #00A0DD;
        }
        
        /* Print Styles for Landscape Letter Size */
        @media print {
            @page {
                size: letter landscape;
                margin: 0.25in;
            }
            
            body {
                padding: 0;
                font-size: 10px;
            }
            
            .header {
                margin: 0;
                padding: 10px;
                page-break-after: avoid;
            }
            
            h1 {
                font-size: 18px;
            }
            
            .subtitle {
                font-size: 11px;
            }
            
            .table-container {
                box-shadow: none;
                padding: 0;
            }
            
            table {
                page-break-inside: auto;
                font-size: 8px;
            }
            
            thead {
                display: table-header-group;
            }
            
            tfoot {
                display: table-footer-group;
            }
            
            tr {
                page-break-inside: avoid;
                page-break-after: auto;
            }
            
            th {
                padding: 8px 6px;
                font-size: 9px;
                position: static;
            }
            
            td {
                padding: 6px 5px;
                font-size: 8px;
                line-height: 1.4;
            }
            
            .medication-name {
                font-size: 9px;
                min-width: 100px;
            }
            
            .comments {
                max-width: 280px;
                font-size: 7px;
                line-height: 1.5;
            }
            
            .goal-param {
                max-width: 120px;
                font-size: 8px;
            }
            
            .footer {
                page-break-before: avoid;
                font-size: 8px;
            }
        }
        
        @media (max-width: 768px) {
            body {
                padding: 10px;
            }
            .header {
                margin: -10px -10px 10px -10px;
                padding: 15px;
            }
            h1 {
                font-size: 20px;
            }
            .subtitle {
                font-size: 12px;
            }
        }
    </style></head>
<body>
    <div class="header">
        <h1>Titratable Medications Reference Table</h1>
    <div class="subtitle">Adventist Health Medication Safety Standards</div>
    <div class="table-container">
    <table>
        <thead>
            <tr>
                <th>Medication</th>
                <th>Standard Concentration</th>
                <th>Standard Dilution</th>
                <th>Goal Parameter</th>
                <th>Loading/Bolus Dose</th>
                <th>Initial Rate</th>
                <th>Increment Change</th>
                <th>Frequency</th>
                <th>Maximum Dose</th>
                <th>Dosing Range</th>
                <th>Order Comments</th>
            </tr>
        </thead>
        <tbody>
            <tr class="neuromuscular-blocker high-alert">
            <td class="medication-name">
                atracurium<br/>
                <span class="warning">**HIGH ALERT**</span>
            </td>
        <td class="concentration">#1: 0.5 mg/mL<br/>#2: 0.2 mg/mL</td>
        <td class="dosing">50 mg/100 mL</td>
        <td class="goal-param">
            <li>TOF 2 / 4</li>
            <li>Ventilator synchrony</li>
            <li>Other</li>
        </td>
        <td>
            <li>0.5 mg/kg</li>
            <li>other</li>
        </td>
        <td>2 mcg/kg/min</td>
        <td>1 mcg/kg/min</td>
        <td>15 min</td>
        <td>15 mcg/kg/min</td>
        <td>1 - 15 mcg/kg/min</td>
        <td class="comments">**HIGH-ALERT DRUG**<br/>
            <br/>WARNING: PARALYZING AGENT - CAUSES RESPIRATORY ARREST. Patient must be ventilated and sedated prior to administration with RASS goal -4. Do not titrate sedation off while on paralytic.
            <br/>Obtain baseline train-of-four prior to beginning infusion.
            <br/>Goal parameter must be monitored and documented every 15 minutes until goal is met.
            <br/>Once goal parameter is met, RN may document goal every 30-60 minutes.
            <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.
            <br/>Discontinue order if rate remains at zero for 23 hours.
            <br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.
        </td>
        </tr>
    <tr class="neuromuscular-blocker high-alert">
        <td class="medication-name">CISatracurium (NIMBEX)<br/>
            <span class="warning">**HIGH ALERT**</span>
        </td>
        <td class="concentration">2 mg/mL</td>
    <td class="dosing">200 mg/100 mL</td>
    <td class="goal-param">
        <li>TOF 2 / 4</li>
        <li>Ventilator synchrony</li>
        <li>Other</li>
    </td>
        <td>
            <li>0.2 mg/kg</li>
            <li>other</li>
        </td>
        <td>1 mcg/kg/min</td>
        <td>1 mcg/kg/min</td>
        <td>15 min</td>
        <td>10 mcg/kg/min</td>
        <td>1 - 10 mcg/kg/min</td>
        <td class="comments">**HIGH-ALERT DRUG**<br/>
            <br/>WARNING: PARALYZING AGENT - CAUSES RESPIRATORY ARREST. Patient must be ventilated and sedated prior to administration with RASS goal -4. Do not titrate sedation off while on paralytic.
            <br/>Obtain baseline train-of-four prior to beginning infusion.
            <br/>Goal parameter must be monitored and documented every 15 minutes until goal is met.
            <br>Once goal parameter is met, RN may document goal every 30-60 minutes.
            <br>Notify provider if maximum dose is met and therapeutic goal is not achieved.
            <br>Discontinue order if rate remains at zero for 23 hours.
            <br>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.
        </td>
</tr>
<tr class="antihypertensive non-formulary">
<td class="medication-name">clevidipine<br/><span style="color: #E24301;">(AH non-formulary)</span></td>
<td class="concentration">0.5 mg/mL</td>
<td class="dosing">50 mg/100 mL <br/>25 mg/50 mL</td>
<td class="goal-param">
        <li>SBP 130 - 150</li>
        <li>SBP 130 - 160</li>
        <li>SBP 140 - 180</li>
        <li>SBP 150 - 180, DBP less than 105</li>
        <li>SBP 150 - 185, DBP less than 110</li>
        <li>SBP 160 - 200</li>
        <li>Other</li>
</td>
<td>none</td>
<td>1 mg/hr</td>
<td>2 mg/hr</td>
<td>2 min</td>
<td>21 mg/hr</td>
<td>1 - 21 mg/hr</td>
<td class="comments">Change vial and tubing every 12 hours.
    <br/>Goal parameter must be monitored and documented every 2 minutes until goal is met. 
    <br/>Once goal parameter is met, RN may document goal every 30-60 minutes.
    <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.
    <br/>Discontinue order if rate remains at zero for 23 hours.
    <br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.
</td>
</tr>
<tr class="sedative">
<td class="medication-name">dexmedeTOMIDine</td>
<td class="concentration">4 mcg/mL</td>
<td class="dosing">400 mcg/100 mL<br/>200 mcg/50mL</td>
<td class="goal-param">RASS 0 to -2</td>
<td>none</td>
<td>0.5 mcg/kg/hr</td>
<td>0.1 mcg/kg/hr</td>
<td>10 min</td>
<td>1.4 mcg/kg/hr</td>
<td>0.1 - 1.4mcg/kg/hr</td>
<td class="comments">Not appropriate alone if patient on neuromuscular blocker (NMB).
    <br/>Goal parameter must be monitored and documented every 10 minutes until goal is met.
    <br/>Once goal parameter is met, RN may document goal every 30-60 minutes.
    <br/>If HR less than 60, decrease rate by half and notify provider.
    <br/>If HR is less than or equal to 50, pause the infusion and notify provider.
    <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.
    <br/>Discontinue order if rate remains at zero for 23 hours.
    <br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="">
<td class="medication-name">dilTIAZem</td>
<td class="concentration">1 mg/mL</td>
<td class="dosing">125 mg/125 mL<br/>100 mg/100 mL</td>
<td class="goal-param">
    <li>HR 60 - 110</li>
    <li>Other</li>
</td>
<td>10 mg, 20 mg, other</td>
<td>5 mg/hr</td>
<td>2.5 mg/hr</td>
<td>15 min</td>
<td>15 mg/hr</td>
<td>2.5 to 15 mg/hr</td>
<td class="comments">Goal parameter must be monitored and documented every 15 minutes until goal is met.    
    <br/>Once goal parameter is met, RN may document goal every 30-60 minutes.
    <br/>Turn IV off 2 hours after oral meds given.
    <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.
    <br/>Discontinue order if rate remains at zero for 23 hours.
    <br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="vasopressor">
    <td class="medication-name">DOBUTamine</td>
    <td class="concentration">#1: 2000 mcg/mL<br/>#2: 4000 mcg/mL</td>
    <td class="dosing">1000 mg/250 mL<br/>500 mg/250 mL</td>
    <td class="goal-param">
            <li> MAP 65 - 75</li> 
            <li> ScVO2 &gt; 70%</li> 
            <li> CI 2 - 4</li> 
            <li> Other</li>
    </td>
    <td>none</td>
    <td>2.5 mcg/kg/min</td>
    <td>2.5 mcg/kg/min</td>
    <td>5 min</td>
    <td>20 mcg/kg/min</td>
    <td>0.5 - 20 mcg/kg/min</td>
    <td class="comments">Goal parameter must be monitored and documented every 5 minutes until goal is met.
        <br/>Once goal parameter is met, RN may document goal every 30-60 minutes.
        <br/>Hold if HR &gt; 140.
        <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.
        <br/>Discontinue order if rate remains at zero for 23 hours.
        <br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.
    </td>
</tr>
<tr class="vasopressor">
    <td class="medication-name">DOPamine</td>
    <td class="concentration">#1: 1600 mcg/mL <br/>#2: 3200 mcg/mL</td>
    <td class="dosing">800 mg/250 mL<br/>400 mg/250 mL</td>
    <td class="goal-param">
        <li>MAP  65 - 75</li>
        <li>Other</li>
    </td>
    <td>none</td>
    <td>2 mcg/kg/min</td>
    <td>2 mcg/kg/min</td>
    <td>2 min</td>
    <td>20 mcg/kg/min</td>
    <td>2 - 20 mcg/kg/min</td>
    <td class="comments">Administration via peripheral line may be considered for up to 24 hours.
        <br/>Rates greater than 10 mcg/kg/min must be administered via a central line.
        <br/>Goal parameter must be monitored and documented every 2 minutes until goal is met.
        <br/>Once goal parameter is met, RN may document goal every 30-60 minutes.
        <br/>Hold if HR > 140.
        <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.
        <br/>Discontinue order if rate remains at zero for 23 hours.
        <br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="vasopressor">
<td class="medication-name">EPINEPHrine</td>
<td class="concentration">#1: 20 mcg/mL<br/>#2: 40 mcg/mL</td>
<td class="dosing">2 mg/100 mL<br/>5 mg/250 mL<br/>10 mg/250 mL</td>
<td class="goal-param">
        <li>MAP  65 - 75</li>
        <li>Other</li>
</td>
<td>none</td>
<td>1 mcg/min</td>
<td>1 mcg/min</td>
<td>2 min</td>
<td>20 mcg/min</td>
<td>1 - 20 mcg/min</td>
<td class="comments">Administration via peripheral line may be considered for up to 24 hours.
    <br/>Rates greater than 15 mcg/min must be administered via a central line.
    <br/>Goal parameter must be monitored and documented every 2 minutes until goal is met.
    <br/>Once goal parameter is met, RN may document goal every 30-60 minutes.
    <br/>Hold if HR > 140.
    <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.
    <br/>Discontinue order if rate remains at zero for 23 hours.
    <br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="antihypertensive">
<td class="medication-name">esmolol</td>
<td class="concentration">#1: 10 mg/mL<br/>#2: 20 mg/mL</td>
<td class="dosing">2500 mg/250 mL<br/>2000 mg/100 mL</td>
<td class="goal-param">
        <li>SBP 100 - 140</li>
        <li>SBP 130 - 160</li>
        <li>SBP 140 - 180</li>
        <li>HR 60 - 110</li>
        <li>Other</li>
</td>
<td>500 mcg/kg, 1000 mcg/kg, other</td>
<td>50 mcg/kg/min</td>
<td>50 mcg/kg/min</td>
<td>5 min</td>
<td>300 mcg/kg/min</td>
<td>50 - 300 mcg/kg/min</td>
<td class="comments">Goal parameter must be monitored and documented every 5 minutes until goal is met.
    <br/>Once goal parameter is met, RN may document goal every 30-60 minutes.
    <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.
    <br/>Discontinue order if rate remains at zero for 23 hours.
    <br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="analgesic">
<td class="medication-name">fentaNYL</td>
<td class="concentration">#1: 10 mcg/mL<br/>#2: 50 mcg/mL</td>
<td class="dosing">2500 mcg/250 mL<br/>1000 mcg/100 mL<br/>5000 mcg/100 mL<br/>500 mcg/50 mL</td>
<td class="goal-param">
    <li>CPOT 0 to 2</li>
    <li>Other</li>
</td>
<td>25 mcg, 50 mcg, 100 mcg, other</td>
<td>50 mcg/hr</td>
<td>25 mcg/hr</td>
<td>60 min</td>
<td>200 mcg/hr</td>
<td>25 - 200 mcg/hr</td>
<td class="comments">WARNING: Medication causes respiratory depression.
    <br/>For Breakthrough Pain (CPOT >2): Bolus 50 mcg every 5 minutes up to 3 times within one hour.
    <br/>If goal is not achieved after 3 consecutive boluses, then increase infusion rate.
    <br/>Goal parameter must be monitored and documented every 60 minutes until goal is met.
    <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.
    <br/>Discontinue order if rate remains at zero for 23 hours.
    <br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="analgesic">
<td class="medication-name">HYDROmorphone</td>
<td class="concentration">#1: 0.2 mg/mL<br/>#2: 1 mg/mL</td>
<td class="dosing">20 mg/100 mL<br/>100 mg/100 mL</td>
<td class="goal-param">
    <li>CPOT 0 to 2</li>
    <li>Other</li>
</td>
<td>0.4 mg, other</td>
<td>0.4 mg/hr</td>
<td>0.2 mg/hr</td>
<td>15 min</td>
<td>2 mg/hr</td>
<td>0.2 - 2 mg/hr</td>
<td class="comments">Goal parameter must be monitored and documented every 15 minutes until goal is met.
    <br/>Once goal parameter is met, RN may document goal every 30-60 minutes.
    <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.
    <br/>Discontinue order if rate remains at zero for 23 hours.
    <br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="vasopressor">
<td class="medication-name">isoproterenol</td>
<td class="concentration">4 mcg/mL</td>
<td class="dosing">1000 mcg/250 mL<br/>2000 mcg/500 mL</td>
<td class="goal-param">
    <li>MAP 65 - 75</li>
    <li>HR 60 - 100</li>
    <li>Other</li>
</td>
<td>none</td>
<td>2 mcg/min</td>
<td>1 mcg/min</td>
<td>5 min</td>
<td>20 mcg/min</td>
<td>1 - 20 mcg/min</td>
<td class="comments">Goal parameter must be monitored and documented every 5 minutes until goal is met.
    <br/> Once goal parameter is met, RN may document goal every 30-60 minutes.
    <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.
    <br/>Discontinue order if rate remains at zero for 23 hours.
    <br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="sedative">
<td class="medication-name">ketamine (Sub-dissociative) (pain)</td>
<td class="concentration">#1: 2 mg/mL<br/>#2: 10 mg/mL</td>
<td class="dosing">500 mg/250 mL<br/>1000 mg/100 mL</td>
<td class="goal-param">
    <li>CPOT 0 to 2</li>
    <li>RASS 0 to - 2</li>
    <li>RASS - 4 to - 5 if on NMB</li>
    <li>Other</li>
</td>
<td>0.25 mg/kg, other</td>
<td>0.05 mg/kg/hr</td>
<td>0.05 mg/kg/hr</td>
<td>60 min</td>
<td>0.3 mg/kg/hr</td>
<td>0.05 - 0.3 mg/kg/hr</td>
<td class="comments">Goal parameter must be monitored and documented every 60 minutes until goal is met.
    <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.
    <br/>Discontinue order if rate remains at zero for 23 hours.
    <br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="sedative">
<td class="medication-name">ketamine (Dissociative)</td>
<td class="concentration">#1: 2 mg/mL<br/>#2: 10 mg/mL</td>
<td class="dosing">500 mg/250 mL<br/>1000 mg/100 mL</td>
<td class="goal-param">
    <li>RASS - 4 to - 5 (if on NMB)</li>
    <li>Other</li>
</td>
<td>1.5 mg/kg, 3 mg/kg, other</td>
<td>1 mg/kg/hr</td>
<td>0.5 mg/kg/hr</td>
<td>60 min</td>
<td>4 mg/kg/hr</td>
<td>1 - 4 mg/kg/hr</td>
<td class="comments">Goal parameter must be monitored and documented every 60 minutes until goal is met.
    <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.
    <br/>Discontinue order if rate remains at zero for 23 hours.
    <br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="">
    <td class="medication-name">labetolol</td>
    <td class="concentration">5 mg/mL</td>
    <td class="dosing">200 mg/40 mL<br/>400 mg/80 mL</td>
    <td class="goal-param">
        <li>SBP 100 - 140</li>
        <li>SBP 130 - 160</li>
        <li>SBP 140 - 180</li>
        <li>HR 60 - 110</li>
        <li>Other</li>
    </td>
    <td>10 mg, 20 mg, other</td>
    <td>1 mg/min</td>
    <td>1 mg/min</td>
    <td>15 min</td>
    <td>4 mg/min</td>
    <td>1 - 4 mg/min</td>
    <td class="comments">Goal parameter must be monitored and documented every 15 minutes until goal is met.
        <br/>Once goal parameter is met, RN may document goal every 30-60 minutes.
        <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.
        <br/>Discontinue order if rate remains at zero for 23 hours.
        <br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.
    </td>
</tr>
<tr class="sedative">
<td class="medication-name">LORazepam</td>
<td class="concentration">1 mg/mL</td>
<td class="dosing">100 mg/100 mL<br/>50 mg/50 mL</td>
<td class="goal-param">
    <li>RASS 0 to - 2</li> 
    <li>Other</li>                              
</td>
<td>1 mg, 2 mg, other</td>
<td>2 mg/hr</td>
<td>1 mg/hr</td>
<td>60 min</td>
<td>10 mg/hr</td>
<td>1 - 10 mg/hr</td>
<td class="comments">Monitor for propylene glycol toxicity.
    <br/>For RASS &gt; 0: Bolus 1 mg every 10 minutes up to 3 times within one hour. If goal is not achieved after 3 consecutive boluses, then increase infusion rate.
    <br/>Goal parameter must be monitored and documented every 60 minutes until goal is met.
    <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.
    <br/>Discontinue order if rate remains at zero for 23 hours.
    <br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="sedative">
<td class="medication-name">midazolam</td>
<td class="concentration">1 mg/mL</td>
<td class="dosing">100 mg/100 mL<br/>50 mg/50 mL</td>
<td class="goal-param">
    <li>RASS 0 to - 2</li>
    <li>RASS - 4 to - 5 if on NMB</li>
    <li>Other</li>
</td>
<td>1 mg, 2 mg, other</td>
<td>2 mg/hr</td>
<td>1 mg/hr</td>
<td>60 min</td>
<td>10 mg/hr</td>
<td>1 - 10 mg/hr</td>
<td class="comments">For RASS &gt; 0: Bolus 2 mg every 5 minutes up to 3 times within one hour. If goal is not achieved after 3 consecutive boluses, then increase infusion rate.
    <br/>Goal parameter must be monitored and documented every 60 minutes until goal is met.
    <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.
    <br/>Discontinue order if rate remains at zero for 23 hours.
    <br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="inotrope">
<td class="medication-name">milrinone</td>
<td class="concentration">#1: 200 mcg/mL<br/>#2: 400 mcg/mL</td>
<td class="dosing">20 mg/100 mL<br/>40 mg/100 mL</td>
<td class="goal-param">
    <li>CI 2 - 4</li>
    <li>Other</li>
</td>
<td>none</td>
<td>0.25 mcg/kg/min</td>
<td>0.125 mcg/kg/min</td>
<td>30 min</td>
<td>0.75 mcg/kg/min</td>
<td>0.125 - 0.75 mcg/kg/min</td>
<td class="comments">Loading dose not typically given due to risk of hypotension. May require vasopressor support.
    <br/>Goal parameter must be monitored and documented every 30 minutes until goal is met.
    <br/>Once goal parameter is met, RN may document goal every 30-60 minutes.
    <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.
    <br/>Discontinue order if rate remains at zero for 23 hours.
    <br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="analgesic">
<td class="medication-name">morphine</td>
<td class="concentration">#1: 1 mg/mL<br/>#2: 5 mg/mL</td>
<td class="dosing">100 mg/100 mL<br/>500 mg/100 mL</td>
<td class="goal-param">
    <li>CPOT 0 to 2</li>
    <li>Other</li>
</td>
<td>2 mg, 4 mg, other</td>
<td>2 mg/hr</td>
<td>1 mg/hr</td>
<td>15 min</td>
<td>20 mg/hr</td>
<td>1 - 20 mg/hr</td>
<td class="comments">Goal parameter must be monitored and documented every 15 minutes until goal is met.
    <br/>Once goal parameter is met, RN may document goal every 30-60 minutes.
    <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.
    <br/>Discontinue order if rate remains at zero for 23 hours.
    <br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="antihypertensive">
<td class="medication-name">niCARdipine (Rapid Titration)</td>
<td class="concentration">#1: 0.1 mg/mL<br/>#2: 0.2 mg/mL</td>
<td class="dosing">20 mg/200 mL<br/>25 mg/250 mL<br/>40 mg/200 mL<br/>50 mg/250 mL</td>
<td class="goal-param">
    <li>SBP 130 - 150</li>
    <li>SBP 130 - 160</li>
    <li>SBP 140 - 180</li>
    <li>SBP 150 - 180 and DBP &lt;105</li>
    <li>SBP 150 - 185 and DBP &lt;110</li>
    <li>SBP 160 - 200</li>
    <li>Other</li>
</td>
<td>none</td>
<td>5 mg/hr</td>
<td>2.5 mg/hr</td>
<td>5 min</td>
<td>15 mg/hr</td>
<td>2.5 - 15 mg/hr</td>
<td class="comments">Central line preferred. It is recommended to change infusion site every 12 hours to minimize peripheral venous irritation. 
    <br/>Goal parameter must be monitored and documented every 5 minutes until goal is met.
    <br/>Once goal parameter is met, decrease infusion rate to 3 mg/hr.
    <br/>Once goal parameter is met, RN may document goal every 30-60 minutes.
    <br/>Hold infusion if SBP is less than 120.
    <br/>Turn IV off 1 hour after oral meds are given.
    <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.
    <br/>Discontinue order if rate remains at zero for 23 hours.
    <br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="antihypertensive">
<td class="medication-name">niCARdipine</td>
<td class="concentration">#1: 0.1 mg/mL<br/>#2: 0.2 mg/mL</td>
<td class="dosing">20 mg/200 mL<br/>25 mg/250 mL<br/>40 mg/200 mL<br/>50 mg/250 mL</td>
<td class="goal-param">
    <li>SBP 130 - 150</li>
    <li>SBP 130 - 160</li>
    <li>SBP 140 - 180</li>
    <li>SBP 150 - 180 and DBP &lt; 105</li>
    <li>SBP 150 - 185 and DBP &lt; 110</li>
    <li>SBP 160 - 200</li>
    <li>Other</li>
</td>
<td>none</td>
<td>5 mg/hr</td>
<td>2.5 mg/hr</td>
<td>15 min</td>
<td>15 mg/hr</td>
<td>2.5 - 15 mg/hr</td>
<td class="comments">Central line preferred. It is recommended to change infusion site every 12 hours to minimize peripheral venous irritation.
    <br/>Goal parameter must be monitored and documented every 15 minutes until goal is met.
    <br/>Once goal parameter is met, RN may document goal every 30-60 minutes.
    <br/>Hold infusion if SBP is less than 120.
    <br/>Turn IV off 1 hour after oral meds are given.
    <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.
    <br/>Discontinue order if rate remains at zero for 23 hours.
    RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="">
<td class="medication-name">nitroglycerin</td>
<td class="concentration">200 mcg/mL</td>
<td class="dosing">50 mg/250 mL</td>
<td class="goal-param">
    <li>SBP 100 - 140</li>
    <li>SBP 130 - 160</li>
    <li>SBP 140 - 180</li>
    <li>Other</li>
</td>
<td>none</td>
<td>10 mcg/min</td>
<td>10 mcg/min</td>
<td>5 min</td>
<td>200 mcg/min</td>
<td>10 - 200 mcg/min</td>
<td class="comments">Non-PVC tubing/container required. Tolerance may begin in 12 to 24 hours.
    <br/>Goal parameter must be monitored and documented every 5 minutes until goal is met.
    <br/>Once goal parameter is met, RN may document goal every 30-60 minutes.
    <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.
    <br/>Discontinue order if rate remains at zero for 23 hours.
    <br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="">
<td class="medication-name">nitroprusside</td>
<td class="concentration">#1: 200 mcg/mL<br/>#2: 500 mcg/mL</td>
<td class="dosing">50 mg/250 mL<br/>50 mg/100 mL</td>
<td class="goal-param">
    <li>SBP 100 - 140</li>
    <li>SBP 130 - 160</li>
    <li>SBP 140 - 180</li>
    <li>Other</li>
</td>
<td>none</td>
<td>0.2 mcg/kg/min</td>
<td>0.2 mcg/kg/min</td>
<td>5 min</td>
<td>4 mcg/kg/min</td>
<td>0.2 - 4 mcg/kg/min</td>
<td class="comments">Protect from light.
    <br/>Goal parameter must be monitored and documented every 5 minutes until goal is met.
    <br/>Once goal parameter is met, RN may document goal every 30-60 minutes.
    <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.
    <br/>Discontinue order if rate remains at zero for 23 hours.
    <br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="vasopressor">
<td class="medication-name">NORepinephrine</td>
<td class="concentration">#1a: 16 mcg/mL<br/>#1b: 32 mcg/mL<br/><br/>#2: 128 mcg/mL</td>
<td class="dosing">4 mg/250 mL                 8 mg/250 mL<br/>32 mg/250mL</td>
<td class="goal-param">
    <li>MAP 65 - 75</li>
    <li>Other</li>
</td>
<td>none</td>
<td>4 mcg/min</td>
<td>2 mcg/min</td>
<td>2 min</td>
<td>30 mcg/min</td>
<td>2 - 30 mcg/min</td>
<td class="comments">Administration via peripheral line may be considered for up to 24 hours.
    <br/>Rates greater than 15 mcg/min must be administered via a central line.
    <br/>Goal parameter must be monitored and documented every 2 minutes until goal is met.
    <br/>Once goal parameter is met, RN may document goal every 30-60 minutes.
    <br/>Contact provider to consider adding vasopressin once dose ≥ 8 mcg/min.
    <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.
    <br/>Discontinue order if rate remains at zero for 23 hours.
    <br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="vasopressor">
<td class="medication-name">phenylephrine</td>
<td class="concentration">#1: 80 mcg/mL<br/>#2: 400 mcg/mL</td>
<td class="dosing">20 mg/250 mL<br/>100 mg/250 mL</td>
<td class="goal-param">
    <li>MAP 65 - 75</li>
    <li>Other</li>
</td>
<td>none</td>
<td>50 mcg/min</td>
<td>10 mcg/min</td>
<td>5 min</td>
<td>200 mcg/min</td>
<td>10 - 200 mcg/min</td>
<td class="comments">Administration via peripheral line may be considered for up to 24 hours.
    <br/>Rates greater than 150 mcg/min must be administered via a central line.
    <br/>Goal parameter must be monitored and documented every 5 minutes until goal is met.
    <br/>Once goal parameter is met, RN may document goal every 30-60 minutes.
    <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.
    <br/>Discontinue order if rate remains at zero for 23 hours.
    <br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="sedative">
<td class="medication-name">propofol</td>
<td class="concentration">10 mg/mL</td>
<td class="dosing">1000 mg/100 mL<br/>500 mg/50 mL</td>
<td class="goal-param">
    <li>RASS 0 to - 2</li>
    <li>RASS - 4 to - 5 if on NMB</li>
    <li>Other</li>
</td>
<td>10 mg, 20 mg, other</td>
<td>10 mcg/kg/min</td>
<td>5 mcg/kg/min</td>
<td>5 min</td>
<td>60 mcg/kg/min</td>
<td>5 - 60 mcg/kg/min</td>
<td class="comments">Change vial and tubing every 12 hours.
    <br/>Check triglycerides at baseline and weekly. Consider more frequent TG level for high dose propofol
    <br/>Goal parameter must be monitored and documented every 5 minutes until goal is met.
    <br/>Once goal parameter is met, RN may document goal every 30-60 minutes.
    <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.
    <br/>Discontinue order if rate remains at zero for 23 hours.
    <br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="neuromuscular-blocker high-alert">
<td class="medication-name">ROCuronium<br/><span class="warning">**HIGH ALERT**</span></td>
<td class="concentration">#1: 1 mg/mL<br/>#2: 10 mg/ml</td>
<td class="dosing">100 mg/100 mL<br/>300 mg/30 mL</td>
<td class="goal-param">
    <li>TOF 2 / 4</li>
    <li>Ventilator synchrony</li>
    <li>Other</li>
</td>
<td>1 mg/kg, other</td>
<td>5 mcg/kg/min</td>
<td>1 mcg/kg/min</td>
<td>15 min</td>
<td>16 mcg/kg/min</td>
<td>1 - 16 mcg/kg/min</td>
<td class="comments">**HIGH-ALERT DRUG**
    <br/>WARNING: PARALYZING AGENT - CAUSES RESPIRATORY ARREST. Patient must be ventilated and sedated prior to administration with RASS goal -4. Do not titrate sedation off while on paralytic
    <br/>Obtain baseline train-of-four prior to beginning infusion.
    <br/>Goal parameter must be monitored and documented every 15 minutes until goal is met.
    <br/>Once goal parameter is met, RN may document goal every 30-60 minutes.
    <br/>Notify provider  if maximum dose is met and therapeutic goal is not achieved.
    <br/>Discontinue order if rate remains at zero for 23 hours.
    <br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
<tr class="neuromuscular-blocker high-alert">
<td class="medication-name">VECuronium<br/><span class="warning">**HIGH ALERT**</span></td>
<td class="concentration">1 mg/mL</td>
<td class="dosing">100 mg/100 mL</td>
<td class="goal-param">
    <li>TOF 2 / 4</li>
    <li>Ventilator synchrony</li>
    <li>Other</li>
</td>
<td>0.1 mg/kg, other</td>
<td>1 mcg/kg/min</td>
<td>0.1 mcg/kg/min</td>
<td>15 min</td>
<td>1.7 mcg/kg/min</td>
<td>0.1 - 1.7 mcg/kg/min</td>
<td class="comments">**HIGH-ALERT DRUG**
    <br/>WARNING: PARALYZING AGENT - CAUSES RESPIRATORY ARREST. Patient must be ventilated and sedated prior to administration with RASS goal -4. Do not titrate sedation off while on paralytic.
    <br/>Obtain baseline train-of-four prior to beginning infusion.
    <br/>Goal parameter must be monitored and documented every 15 minutes until goal is met.
    <br/>Once goal parameter is met, RN may document goal every 30-60 minutes.
    <br/>Notify provider if maximum dose is met and therapeutic goal is not achieved.
    <br/>Discontinue order if rate remains at zero for 23 hours.
    <br/>RN may restart infusion at the initial rate or the last documented rate if it is lower than the initial rate if infusion is paused.</td>
</tr>
</tbody>
</table>
</div>
<div class="footer">
<strong>Adventist Health</strong> | Medication Safety Standards<br/>
        For internal use only | Updated: November 2025
    </div>
</div></body>
</html>
